PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-02-15

Date Title Company
15-Feb-2023 Mahana Therapeutics Appoints Justin Zamirowski, Jr. as Chief Commercial Officer Businesswire
15-Feb-2023 Bryn Pharma UTULY™ Phase 3 Data accepted as Late-Breaker at the 2023 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting Businesswire
15-Feb-2023 NaturalShrimp Collaborates with Australian Companies in a Prawn Farm Wastewater Trial Businesswire
15-Feb-2023 Antibe Reports Q3 2023 Interim Financial and Operating Results Businesswire
15-Feb-2023 New Survey Reveals 73% of Pharmacists Say Amoxicillin Shortage Continues Businesswire
15-Feb-2023 GlycoMimetics Announces Continuation of Phase 3 Study of E-selectin Antagonist Uproleselan in Relapsed/Refractory AML to Originally Planned Final Analysis Following Interim Analysis by Independent Data Monitoring Committee Businesswire
15-Feb-2023 Leading Universities Adopt BioTalent Canada’s Skills Courses To Improve Student Job-Readiness Businesswire
15-Feb-2023 Nanite Debuts AI-Driven Polymer Design Platform for Gene Delivery Businesswire
15-Feb-2023 TAE Life Sciences Announces First Cancer Patient Treatments Using Accelerator-Based Biologically Targeted Radiation Therapy (BNCT) Businesswire
15-Feb-2023 Direct Biologics Appoints Dr. Amy Lightner as Chief Medical Officer Businesswire
15-Feb-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
15-Feb-2023 Arrowhead Pharmaceuticals Gains Full Rights to NASH Candidate ARO-PNPLA3 with Promising Phase 1 Results Businesswire
15-Feb-2023 FSD Pharma Regains Compliance with NASDAQ Continued Listing Requirements Businesswire
15-Feb-2023 Asahi Kasei Completes Second Plant for Ceolus™ Microcrystalline Cellulose Businesswire
15-Feb-2023 Coya Therapeutics, Inc. Announces Expansion of Exclusive Worldwide Licensing Agreement with ARScience Biotherapeutics, Inc. for Development and Commercialization of COYA 301, Coya’s Low-Dose Interleukin 2 (IL-2) Product Candidate Businesswire
15-Feb-2023 Glaukos Announces Participation in the Citi Healthcare Conference Businesswire
15-Feb-2023 Harrow Launches Next-Generation Compounded Atropine Formulations Businesswire
15-Feb-2023 Identiv Enters Exclusive Strategic Manufacturing and Channel Agreement with Trace-ID Businesswire
15-Feb-2023 Bausch + Lomb Appoints Brent Saunders as Chief Executive Officer and Chair of the Board of Directors, Effective March 6, 2023 Businesswire
15-Feb-2023 Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2022 Financial Results Businesswire